By Adriano Marchese
McKesson has agreed to acquire a controlling interest in eye-health company PRISM Vision Holdings for $850 million as it looks to develop a retinal and ophthalmology platform.
The diversified healthcare services company said Tuesday it will acquire an 80% stake in the company, while PRISM Vision physicians will continue to retain a 20% interest in the business.
McKesson chief executive, Brian Tyler, said the acquisition strengthens its community practice and specialty solutions, while building a platform to serve a high-growth area of retina and ophthalmology.
"We intend to develop a leading platform for retinal care, delivering differentiated solutions and value across providers, biopharma partners and patients," Tyler said.
McKesson expects PRISM Vision to add about 20 cents to 30 cents to its adjusted earnings per share in the first 12 months following the close of the transaction, and then to be between 65 cents and 75 cents accretive by the end of the third year.
Write to Adriano Marchese at adriano.marchese@wsj.com
(END) Dow Jones Newswires
February 04, 2025 08:30 ET (13:30 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。